Sandu Pharmaceuticals Limited (BOM:524703)

Sandu Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	37.21	26.53	12.06	22.76	9.39	45.28
Short-Term Investments	-	-	-	0.2	32.33	71.28
Cash & Short-Term Investments	37.21	26.53	12.06	22.96	41.71	116.56
Cash Growth	11.58%	119.93%	-47.45%	-44.96%	-64.21%	656.09%
Accounts Receivable	73.53	47.57	48.68	47.92	39.91	53.48
Other Receivables	-	0.32	0.62	3.17	4.28	1.24
Receivables	73.53	49.12	50.32	52.13	45.09	54.92
Inventory	110.03	141.49	122.51	143.26	112.72	111.38
Prepaid Expenses	-	1.86	1.15	0.76	0.87	1.81
Other Current Assets	47.83	43.99	37	36.35	36.08	20.76
Total Current Assets	268.59	262.99	223.04	255.45	236.47	305.43
Property, Plant & Equipment	183.29	181.22	178.43	169.86	164.5	161.06
Long-Term Investments	116.09	112.74	122.33	115.61	91.39	2.46
Other Intangible Assets	0.2	0.24	0.35	0.51	0.35	0.68
Other Long-Term Assets	-	-	0	0.24	0.14	0
Total Assets	568.18	557.19	524.15	541.66	492.85	469.63
Accounts Payable	42.27	44.87	41.95	83.98	68.18	66.7
Accrued Expenses	57.67	30.36	32.98	29.07	25.65	40.88
Short-Term Debt	-	-	-	-	-	0.19
Current Portion of Leases	0.56	0.58	0.03	-	-	-
Current Income Taxes Payable	-	25	19.12	13.25	15.28	8.32
Current Unearned Revenue	-	6.69	5.15	7.3	6.06	5.34
Other Current Liabilities	28.19	13.36	7.19	5.24	3.57	3.76
Total Current Liabilities	128.68	120.86	106.41	138.83	118.74	125.19
Long-Term Leases	3.92	4.19	0.6	-	-	-
Long-Term Deferred Tax Liabilities	13.24	11.97	11.21	10.42	9.37	9.53
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	145.84	137.02	118.22	149.25	128.1	134.72
Common Stock	96.61	96.61	96.61	96.61	88.11	79.21
Additional Paid-In Capital	-	27.58	27.58	27.58	18.49	8.98
Retained Earnings	-	190.27	180.88	171.95	161.8	144.76
Comprehensive Income & Other	325.73	105.71	100.86	96.27	96.35	101.96
Shareholders' Equity	422.34	420.17	405.93	392.41	364.75	334.91
Total Liabilities & Equity	568.18	557.19	524.15	541.66	492.85	469.63
Total Debt	4.48	4.78	0.63	-	-	0.19
Net Cash (Debt)	32.72	21.76	11.43	22.96	41.71	116.37
Net Cash Growth	16.14%	90.33%	-50.21%	-44.96%	-64.16%	3823.48%
Net Cash Per Share	3.38	2.25	1.18	2.43	4.91	16.43
Filing Date Shares Outstanding	9.71	9.66	9.66	9.66	8.81	7.92
Total Common Shares Outstanding	9.71	9.66	9.66	9.66	8.81	7.92
Working Capital	139.91	142.13	116.63	116.62	117.74	180.24
Book Value Per Share	43.50	43.49	42.02	40.62	41.40	42.28
Tangible Book Value	422.14	419.93	405.58	391.91	364.4	334.23
Tangible Book Value Per Share	43.48	43.47	41.98	40.57	41.36	42.20
Buildings	-	86.16	86.16	85.84	81.31	81.31
Machinery	-	102.66	97.61	81.87	75.42	71.83
Construction In Progress	-	-	-	4.2	4.82	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.